Insider Selling: ASP Isotopes (NASDAQ:ASPI) CEO Sells 83,758 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) CEO Paul Mann sold 83,758 shares of the business’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $3.91, for a total value of $327,493.78. Following the transaction, the chief executive officer directly owned 9,496,087 shares of the company’s stock, valued at $37,129,700.17. The trade was a 0.87% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Paul Elliot Mann also recently made the following trade(s):

• On Friday, September 4th, Paul Mann sold 83,759 shares of ASP Isotopes stock. The shares were sold at an average price of $4.10, for a total transaction of $343,411.90.

ASP Isotopes Price Performance

Shares of ASP Isotopes stock traded up $0.30 on Friday, hitting $4.20. 3,831,544 shares of the company traded hands, compared to its average volume of 2,936,087. The firm’s 50-day simple moving average is $4.37 and its 200 day simple moving average is $5.20. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. The company has a market cap of $643.90 million, a P/E ratio of -3.18 and a beta of 3.59. ASP Isotopes Inc. has a 12-month low of $3.51 and a 12-month high of $14.49.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.The company had revenue of $5.12 million for the quarter, compared to the consensus estimate of $4.47 million.

Institutional Trading of ASP Isotopes

Several hedge funds have recently added to or reduced their stakes in ASPI. Amundi bought a new position in shares of ASP Isotopes during the second quarter valued at about $107,000. California State Teachers Retirement System lifted its stake in shares of ASP Isotopes by 864.2% in the 2nd quarter. California State Teachers Retirement System now owns 754,131 shares of the company’s stock valued at $4,691,000 after acquiring an additional 675,919 shares during the last quarter. AXQ Capital LP bought a new stake in shares of ASP Isotopes in the 2nd quarter valued at about $80,000. Headlands Technologies LLC boosted its holdings in ASP Isotopes by 219.6% during the 2nd quarter. Headlands Technologies LLC now owns 240,197 shares of the company’s stock valued at $1,494,000 after acquiring an additional 165,031 shares during the period. Finally, Alyeska Investment Group L.P. boosted its holdings in ASP Isotopes by 5.6% during the 2nd quarter. Alyeska Investment Group L.P. now owns 2,843,503 shares of the company’s stock valued at $17,687,000 after acquiring an additional 151,337 shares during the period. 16.80% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ASPI has been the subject of a number of research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Wall Street Zen raised ASP Isotopes from a “strong sell” rating to a “sell” rating in a report on Saturday, August 22nd. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.